AROMASIN for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where AROMASIN was used for Neoplasm malignant.
Most Reported Side Effects for AROMASIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 23 | 17.2% | 11 | 1 |
| Breast cancer | 22 | 16.4% | 10 | 2 |
| Arthralgia | 11 | 8.2% | 0 | 0 |
| Fatigue | 10 | 7.5% | 0 | 1 |
| Insomnia | 9 | 6.7% | 0 | 0 |
| Headache | 8 | 6.0% | 0 | 0 |
| Pain | 8 | 6.0% | 1 | 0 |
| Diarrhoea | 7 | 5.2% | 0 | 0 |
| Malaise | 7 | 5.2% | 0 | 1 |
| Neoplasm malignant | 7 | 5.2% | 0 | 0 |
| Neuropathy peripheral | 7 | 5.2% | 0 | 0 |
| Alopecia | 5 | 3.7% | 0 | 0 |
| Dyspnoea | 5 | 3.7% | 1 | 1 |
| Second primary malignancy | 5 | 3.7% | 4 | 1 |
| Weight decreased | 5 | 3.7% | 0 | 0 |
Other Indications for AROMASIN
Breast cancer (51)
Breast cancer metastatic (15)
Breast cancer female (8)
Product used for unknown indication (6)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)